Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity

Arch Toxicol. 2002 Mar;76(2):119-21. doi: 10.1007/s00204-001-0307-5. Epub 2002 Jan 23.

Abstract

Recently we have shown that post-exposure treatment with povidone iodine (PI) protects against nitrogen and sulfur mustard-induced skin lesions. Since proteolytic activity is involved in skin damage caused by chemical irritants, we have studied the effect of iodine on mechlorethamine (HN2)-induced skin collagenolytic activities in the haired guinea pig model. The matrix metalloproteinase-9 (MMP-9) activity increased by 30, 46, 12 and 23% after 3, 24, 48 and 72 h of HN2 exposure, respectively, whereas the MMP-2 was elevated by 8, 65, 8 and 30%, respectively. Topical treatment with PI at 15 and 120 min after HN2 exposure decreased the MMP-9 activity by 67% and 60%, respectively, when skin was analyzed 3 h after exposure. The same trend was observed in the MMP-2 and MMP-1 activities after PI treatment. A stronger effect of PI treatment 15 min following exposure was observed in skin analyzed 24 h after exposure, i.e. a decrease of 83% and 88% in MMP-9 and MMP-2 activities, respectively. Similar findings were observed with an interval of 120 min between HN2 exposure and PI treatment. A much weaker effect was observed on MMP-1 activity. A similar trend of PI-induced reduction in the three types of collagenase activity was found in skin analyzed 48 and 72 h after exposure. Reduced collagenolytic activity may serve as one of the mechanisms by which iodine protects the skin against chemical insult.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Topical
  • Animals
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Disease Models, Animal
  • Guinea Pigs
  • Irritants / toxicity*
  • Male
  • Matrix Metalloproteinases / metabolism*
  • Mechlorethamine / toxicity*
  • Povidone-Iodine / administration & dosage
  • Povidone-Iodine / therapeutic use*
  • Skin / drug effects
  • Skin / enzymology*
  • Skin Diseases / chemically induced
  • Skin Diseases / enzymology
  • Skin Diseases / prevention & control*

Substances

  • Dermatologic Agents
  • Irritants
  • Mechlorethamine
  • Povidone-Iodine
  • Matrix Metalloproteinases